Adili Tsaba
Director Técnico/Científico/I+D en VESSL Therapeutics Ltd. .
Cargos activos de Adili Tsaba
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Director Técnico/Científico/I+D | 01/01/2001 | - |
| Consejero General | 01/01/2001 | - |
Historial de carrera de Adili Tsaba
Formación de Adili Tsaba.
| Technion-Israel Institute of Technology | Undergraduate Degree |
Estadísticas
Internacional
| Israel | 3 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Adili Tsaba
- Experiencia
